Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neoplasm Metastasis × Erlotinib Hydrochloride × Clear all

Phase

Phase 2 12 Phase 1 12 Phase 3 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Oligometastatic Lung Adenocarcinoma 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 EGFR Mutation Positive Non-small Cell Lung Cancer 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Radiosurgery 21 Magnetic Resonance Spectroscopy 11 Cryosurgery 9 Blood Specimen Collection 9 Standard of Care 8 Radiotherapy 7 Surveys and Questionnaires 6 Educational Status 6 Drug Therapy 6 Radiotherapy, Intensity-Modulated 5 Palliative Care 5 Surgical Procedures, Operative 4 Practice Guidelines as Topic 4 Methods 4 Everolimus 4 Radiofrequency Ablation 3 Early Intervention, Educational 3 Cryotherapy 3 Androgen Antagonists 3 Zoledronic Acid 2 Videotape Recording 2 Trastuzumab 2 Radiation 2 Physical Therapy Modalities 2 Manual Lymphatic Drainage 2 Liver Transplantation 2 Liquid Biopsy 2 Letrozole 2 Interviews as Topic 2 Genetic Profile 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01190241 2020-11-20

TSAP

Amsterdam UMC, location VUmc

Phase NA Terminated

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡